Are homes under $500K an endangered species on the South Shore? What the numbers show
A single-family home going for less than $500,000 on the South Shore might as well be an endangered species.
No community in the region had a year-end median sale price of a single-family home sold in 2024 that was below a half million dollars, according to data collected by The Warren Group.
It's possible, but difficult, to come by one as of late, as evidenced by rising median sale price in the region and across the state. The median home sale price in the state reached $615,000 last year, an increase of 7.9%. On the South Shore, that year-over-year change amounted to a 6.3% jump, to $680,000.
A little more than a dozen single-family homes on the South Shore were listed for sale on Zillow for under $500,000 as of the end of January.
Randolph had a median sale price of $560,000, which was a 10.5% increase over the previous year.
Abington's median sale price was $557,750, or a 13% increase.
Carver had a median sale price of $525,000 last year, an 18.5% jump.
The median sale price in Whitman was $510,000, or a 9.6% increase.
Rockland's median sale price was $505,000, amounting to a 18.9% increase.
More: Median home sale price reaches $1M in 2 South Shore towns: Where it went up and down
The COVID-19 pandemic shook the real estate industry. With a smaller housing stock, home prices were turbocharged.
In 2019, the median sale price was under $500,000 for a dozen South Shore communities. Carver, for example, had a median sale price of $337,700 that year. The highest in this category was Marshfield, at $460,000.
Over the years, the median home sale price has steadily increased. In 2020, the median sale price was under a half-million dollars in 11 communities in the region. The following year, that amount dipped to seven communities; then four in 2022; and two, Whitman and Rockland, in 2023.
At a slower rate, more and more South Shore communities had passed the $1 million median sale price mark. First, it was Cohasset in 2020, followed by Hingham in 2021. Duxbury became the third to pass this milestone in 2023.
Now, five South Shore communities hold this distinction of the median sale price of a single-family home being over $1 million, adding Norwell and Milton.
Hannah Morse covers growth and development for The Patriot Ledger. Contact her at hmorse@patriotledger.com.
This article originally appeared on The Patriot Ledger: Least expensive median South Shore sale price in 2024 topped $500,000
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Entrepreneur
4 hours ago
- Entrepreneur
6 Steps That Helped Me Lead Through Three Global Crises
Feeling afraid is natural. But feeling afraid every day? That's not sustainable, especially for entrepreneurs. Opinions expressed by Entrepreneur contributors are their own. In 2000, I was head of the first fintech in Mexico, Finanzas Web. A company so innovative that we survived the market collapse when the dot-com bubble burst because we had capital reserves and a clear execution plan. In 2008, the Great Recession hit, and I was in the eye of the hurricane with a business specializing in mortgages for the Hispanic market. When the bank cut our lending overnight, I lost the company and was left with $1 million in personal debt. Third time's the charm, right? In 2020, amid COVID, my current company, Growth Institute, was prepared. We doubled revenue and made the Inc. 5000 list for the third consecutive year. We came out stronger than ever. Same CEO. Same world. Different outcomes. So, what changed? Better systems, deeper awareness and a disciplined mindset. Related: Fear Can Hold Us Back – But It Can Also Drive Us Forward. Here's How to Turn Fear Into Fuel. Step 1: Name the fear The first step in managing fear is naming it. Psychologists Justin Milano and Dan Cordaro emphasize that high-performing entrepreneurs don't deny fear — they study it. When fear arises, don't suppress it. Ask: What's the fear? Where do I feel it in my body? Is it rooted in a real threat or in a future that may never happen? Anxiety often stems from mental loops rather than concrete facts. For instance: "What if we run out of cash?" or "What if the product fails?" These fears narrow your thinking, reducing your ability to problem-solve. When you label the fear, you reclaim power over it. Step 2: Shift the lens Fear signals potential loss. But what if it's pointing to opportunity? Milano and Cordaro outline three common fear mindsets: Scarcity: Believing there's never enough. Aversion: Resisting reality as it is. Unworthiness: Feeling inadequate. The moment you shift from "What might I lose?" to "What could I gain?" you take back control. Related: 3 Steps to Overcome the Fear of Uncertainty and Daily Stress Step 3: Build systems before the storm Jim Collins coined the term Return on Luck, which he defines as the ability to turn unexpected events—good or bad — into momentum for scaling. And here's the key insight: successful and unsuccessful companies receive the same amount of luck. The difference is in what they do with it. How to increase your Return on Luck: Stay alert: Opportunities rarely look like opportunities at first. Act with discipline: Minimize emotions. Rely on data and strategy. Learn fast: Every crisis brings a lesson. Are you listening? Be consistent: Don't change course with every breeze. Discipline sets you free. ROL allowed my companies to collapse or scale, depending on our preparedness. So ask yourself: Do we have a system for cash flow management? Do we have KPIs we monitor weekly? Can our team execute without micromanagement? Luck is unpredictable — but your response to it isn't. Adopting a disciplined mindset can turn uncertainty into growth and lasting success. Train for chaos before it arrives. Step 4: Tighten your execution disciplines In times of uncertainty, operational discipline becomes your safety net. Think of your business like a car. Without a dashboard — clear KPIs, priorities and communication rhythms — you're driving blind. Go back to the basics: Define your top priorities. Hold daily and weekly huddles to maintain alignment. Make your metrics visible and reviewed consistently. Beyond the mechanics, reinforce your company's strategy and values in every meeting. Be vocal. Be repetitive. Leadership means becoming a constant messenger of your vision. And don't just trust your gut. Use data. In uncertain markets, instinct can be misleading. Stay alert to trends, benchmark your performance, and course-correct early. Finally, empower your team. Give clear direction, then step back. Agility comes from confident, decentralized execution, not from micromanagement. Related: Leading With Transparency in Times of Uncertainty Step 5. Lead with transparency and strategy In crisis, communication becomes your most powerful tool. It's not enough to have a strategy. You must communicate it clearly and consistently. That means: Articulating your vision in simple, repeatable terms Listening to your team's concerns without judgment Staying transparent during tough calls Leadership is not about having all the answers but showing the path forward. Step 6: Negotiate like a pro During economic instability, one of the most overlooked levers is your supplier relationships. While most CEOs rush to cut headcount or pause marketing, the smart ones call their vendors. Consider this approach: "Like you, we're feeling the pressure. Let's revisit our agreement and find a win-win." You might be surprised how flexible suppliers become when the relationship is strong. Here are quick wins to explore: Extended payment terms Lower minimum commitments Locked-in pricing for more extended periods Proactive negotiation in times of uncertainty isn't a risk. It's strategic leadership. You can't eliminate fear, but you can lead through it Fear doesn't disappear as you scale; it evolves. However, so can your strategies and resilience. The best entrepreneurs don't wait for confidence to act. They act their way into confidence. As someone who's experienced three major crises and emerged stronger on the other side, my advice is this: Don't try to outrun fear. Make it your ally.
Yahoo
4 hours ago
- Yahoo
FTSE 100 hits new record as investors fish for non-US stocks
The FTSE 100 has hit a new closing record after investors 'fished for opportunities' outside the US, despite the UK economy shrinking by more than expected in April. The index of the UK's leading shares rose 0.23% to close at 8,884 on Thursday, topping a previous high of 8,871.31 on March 3. Shares have rallied in recent days and that continued on Thursday despite Chancellor Rachel Reeves acknowledging 'clearly disappointing' new gross domestic product (GDP) figures. The Office for National Statistics said GDP fell by 0.3% in April, marking the biggest contraction since October 2023 and worse than the 0.1% decline expected by most economists. But the FTSE 100's global footprint, with constituents including mining and energy giants, helped lift it to new heights. The London index has staged a significant recovery since suffering sharp drops in the days after Donald Trump's tariff announcements on April 2. It had its worst day of trading since the start of the Covid pandemic, while European, US and Asian indexes also took a battering. However, most indexes, including the FTSE and the US's S&P 500, have since recovered their losses as the US has struck new trade deals with countries including the UK and China. Dan Coatsworth, investment analyst at AJ Bell, said: 'The UK stock market has been a star performer this year, delivering more than three times the return as the S&P 500 in the US. 'It's been ages since the UK trumped the US on the stock market, and 2025 has been the breakthrough year. 'Driving the FTSE 100 this year have been precious metal miners including Fresnillo, defence stocks Babcock, BAE Systems and Rolls-Royce, and financials such as Lloyds and Prudential. 'It's been an eventful first half of the year, with many investors turning their backs on the US amid concerns about Donald Trump's trade policies and how they might hurt the economy. 'They've fished for opportunities across the pond, with Europe being a magnet thanks to its cheaper markets relative to the US. 'The UK market has done well, but Germany has done even better thanks to the government's plans to splash the cash on defence and infrastructure.' Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Yahoo
BioNTech bolsters mRNA pipeline with $1.25bn CureVac acquisition
BioNTech has agreed to acquire mRNA specialist CureVac for approximately $1.25bn, as the big pharma company amps up its strategy to offer cancer treatments using the modality. According to the deal, each CureVac share will be exchanged for approximately $5.46 in BioNTech American depositary shares (ADS). This gives an aggregate equity value of around $1.25bn for CureVac. The transaction will see BioNTech assimilate its former rival in the Covid-19 vaccine arena. The pharma companies said the deal will 'bring together two highly complementary companies based in Germany' that can 'fully realise the transformative potential of mRNA medicine'. Shares in BioNTech rose 0.17% at market open on 12 July, reaching a price of $105.64, following the announcement. The pharma company has a market cap of $25.3bn. The agreement underscores BioNTech's strategy to become a dominant player in mRNA-based cancer immunotherapies. The company has struggled with revenue in recent years as demand waned for Covid-19-related products. However, it could be well positioned to harness the oncology market given its strong expertise in mRNA technology – a modality that has already showed promise in clinical trials. 'BioNTech aims to strengthen the research, development, manufacturing, and commercialisation of investigational mRNA-based cancer immunotherapy,' BioNTech said in a statement accompanying the acquisition. In July 2024, CureVac streamlined its focus towards oncology after selling influenza and Covid-19 vaccine development to GSK in a deal worth nearly €1.5bn. This is the second big oncology deal for BioNTech this month, after MSD licensed a bispecific cancer drug from the company in a deal rising to a potential $11bn. BioNTech's CEO Ugur Sahin said: 'This transaction is another building block in BioNTech's oncology strategy and an investment in the future of cancer medicine. 'We intend to bring together complementary capabilities and leverage technologies with the goal of advancing the development of innovative and transformative cancer treatments and establishing new standards of care for various types of cancer in the coming years.' BioNTech also bolstered its cancer platform in November 2024 when it acquired oncology biotech Biotheus for an upfront payment of $800m. "BioNTech bolsters mRNA pipeline with $1.25bn CureVac acquisition" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
